Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway
Min-Ting Lin, Hong Bi, Yanyan Yan, et al.
Oncotarget (2017) Vol. 8, Iss. 14, pp. 23436-23447
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Advances in chemistry and bioactivity of parthenolide
Robert R. A. Freund, Philipp Gobrecht, Dietmar Fischer, et al.
Natural Product Reports (2019) Vol. 37, Iss. 4, pp. 541-565
Closed Access | Times Cited: 148
Natural therapeutics and nutraceuticals for lung diseases: Traditional significance, phytochemistry, and pharmacology
Md. Mominur Rahman, Shabana Bibi, Md. Saidur Rahaman, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113041-113041
Open Access | Times Cited: 122
Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin α2β1
Wenjing Huang, Yanyan Yan, Yun Liu, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 115
Redox Paradox: A Novel Approach to Therapeutics-Resistant Cancer
Luksana Chaiswing, William H. St. Clair, Daret K. St. Clair
Antioxidants and Redox Signaling (2018) Vol. 29, Iss. 13, pp. 1237-1272
Open Access | Times Cited: 114
Lung Cancer Stem Cells and Cancer Stem Cell-targeting Natural Compounds
Arnatchai Maiuthed, Wipa Chantarawong, Pithi Chanvorachote
Anticancer Research (2018) Vol. 38, Iss. 7, pp. 3797-3809
Open Access | Times Cited: 90
PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake
Jianye Zhang, Yanyan Yan, Jiajun Li, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 83
Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells
Charles A. Berdan, Raymond Ho, Haley S. Lehtola, et al.
Cell chemical biology (2019) Vol. 26, Iss. 7, pp. 1027-1035.e22
Open Access | Times Cited: 81
Nicotine promotes brain metastasis by polarizing microglia and suppressing innate immune function
Shih-Ying Wu, Fei Xing, Sambad Sharma, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 8
Open Access | Times Cited: 80
Plants as a Source of Anticancer Agents: From Bench to Bedside
Wamidh H. Talib, Safa Daoud, Asma Ismail Mahmod, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4818-4818
Open Access | Times Cited: 46
Parthenolide alleviates microglia‐mediated neuroinflammation via MAPK/TRIM31/NLRP3 signaling to ameliorate cognitive disorder
Mingde Fan, Chao Wang, Xueying Zhao, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110287-110287
Closed Access | Times Cited: 23
Integrated Bioinformatics Analysis the Function of RNA Binding Proteins (RBPs) and Their Prognostic Value in Breast Cancer
Ke Wang, Ling Li, Liang Fu, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 70
Targeting Ras-ERK cascade by bioactive natural products for potential treatment of cancer: an updated overview
Eunüs S. Ali, Shamima Akter, Sarker Ramproshad, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 34
Application of Nanoparticles in the Treatment of Lung Cancer With Emphasis on Receptors
Jingyue Wang, Tong Zhou, Ying Liu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 32
Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties
Daniela Carlisi, Marianna Lauricella, Antonella D’Anneo, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 514-514
Open Access | Times Cited: 29
The use of nanoparticles for targeted drug delivery in non-small cell lung cancer
Jessica E. Holder, Christopher J. Ferguson, Elisabete Oliveira, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 22
Bitter taste signaling in cancer
Ana R. Costa, Ana Catarina Duarte, Ana Raquel Costa‐Brito, et al.
Life Sciences (2023) Vol. 315, pp. 121363-121363
Open Access | Times Cited: 19
Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing P53 - dependent apoptosis and inhibiting VEGF expression
Wamidh H. Talib, Lina T. Al Kury
Biomedicine & Pharmacotherapy (2018) Vol. 107, pp. 1488-1495
Closed Access | Times Cited: 57
Berberine, a natural plant alkaloid, synergistically sensitizes human liver cancer cells to sorafenib
Yuezhao Huang, Kunyuan Wang, Chengxin Gu, et al.
Oncology Reports (2018)
Open Access | Times Cited: 55
The combined administration of parthenolide and ginsenoside CK in long circulation liposomes with targeted tLyp-1 ligand induce mitochondria-mediated lung cancer apoptosis
Xin Jin, Jianping Zhou, Zhenhai Zhang, et al.
Artificial Cells Nanomedicine and Biotechnology (2018) Vol. 46, Iss. sup3, pp. 931-942
Open Access | Times Cited: 48
The targeting of non‑coding RNAs by curcumin: Facts and hopes for cancer therapy (Review)
Yun Liu, Hongmei Sun, Bolat Makabel, et al.
Oncology Reports (2019)
Open Access | Times Cited: 48
Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies
Joana Jorge, Joana Neves, Raquel Alves, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9167-9167
Open Access | Times Cited: 16
Promising Combinatorial Therapeutic Strategies against Non-Small Cell Lung Cancer
Prabhjot Kaur, Santosh Kumar Singh, Manoj K. Mishra, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2205-2205
Open Access | Times Cited: 5
Collateral Sensitivity of Parthenolide via NF-κB and HIF-α Inhibition and Epigenetic Changes in Drug-Resistant Cancer Cell Lines
Mona Dawood, Edna Ooko, Thomas Efferth
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 38
Parthenolide inhibits human lung cancer cell growth by modulating the IGF‑1R/PI3K/Akt signaling pathway
Longhua Sun, Wenxin Yuan, Guilan Wen, et al.
Oncology Reports (2020) Vol. 44, Iss. 3, pp. 1184-1193
Open Access | Times Cited: 34
Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents
Xingchen Liu, Xiaobing Wang
Chinese Journal of Natural Medicines (2022) Vol. 20, Iss. 11, pp. 814-829
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top